Market revenue in 2023 | USD 38.2 million |
Market revenue in 2030 | USD 67.2 million |
Growth rate | 8.4% (CAGR from 2023 to 2030) |
Largest segment | Volumetric infusion pumps |
Fastest growing segment | Insulin Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other Infusion Pumps |
Key market players worldwide | Baxter International Inc, B. Braun, Medtronic PLC, Micrel Medical Devices, Boston Scientific Corp, Fresenius SE & Co KGaA, Roche Holding AG, Tandem Diabetes Care Inc, Terumo Corp, Moog Inc A, IRadimed Corp, CareFusion, Smiths Group PLC, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous infusion pumps market will help companies and investors design strategic landscapes.
Volumetric infusion pumps was the largest segment with a revenue share of 16.75% in 2023. Horizon Databook has segmented the South Korea intravenous infusion pumps market based on volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, implantable infusion pumps, other infusion pumps covering the revenue growth of each sub-segment from 2018 to 2030.
In South Korea, infusion therapy is widely used for pain management, chemotherapy, dehydration, and nutrition supply. South Korea has experienced rapid demographic shift due to decreasing mortality and declining fertility rates.
In 2018, WHO and the UN tagged South Korea as an aging society. In 2019, there were approximately 7.7 million people aged 65 years and above in South Korea and the country is aging faster than any other developed country globally.
The rise in its aging population is accompanied by an increase in the prevalence of chronic diseases, with most deaths being caused by Alzheimer’s (92.3%), lung cancer (24.2%), and heart diseases (20%), according to the Institute of Health Metrics and Evaluation. South Korea has a solid healthcare infrastructure with affordable treatments and advanced medical devices.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea intravenous infusion pumps market , including forecasts for subscribers. This country databook contains high-level insights into South Korea intravenous infusion pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account